Kannaway, LLC ("Kannaway" or "Company"), the first cannabis network
marketing company that focuses on hemp botanical products, is
hosting its inaugural convention during Colorado's "420 weekend"
April 18th-19th at the Sheraton – Downtown Denver, 1550 Court
Place, Denver, Colorado 80202. Kannaway currently has over 60,000
marketing professionals in its network and more than 9,500 Brand
Ambassadors.The Company estimates it will exceed 10,000 Brand
Ambassadors by the day of the convention.
"We're excited to be launching and sharing the Kannaway message
during the '420 weekend' event in Denver," says Kannaway CEO Jeff
Rogers. "Many people today think that hemp is marijuana and that it
is all about THC and getting 'high'. That is simply not true.
Kannaway is all about hemp, not marijuana. Through our exclusive
supplier agreement with HempMeds, we hope to change that
perception. We are able to bring our exclusive CBD-rich hemp oil
products to households nationwide.
"The fact is that cannabidiol is a story that needs to be told,
and through relationship marketing we're going to take the truth
about cannabis and our CBD-rich hemp oil products back to
mainstream America."
Kannaway's business focus is to provide lifestyle products that
include cannabidiol (CBD)-rich hemp oil through its network of
Brand Ambassadors nationwide, leveraging a five-year exclusive
agreement between the Company and KannaLife Sciences, Inc.
("KannaLife") for product development. KannaLife Sciences, Inc. is
a socially responsible, bio-pharmaceutical and phyto-medical
company that specializes in the research and development of
pharmacological products derived from plants. KannaLife holds an
exclusive license agreement with the National Institutes of Health
– Office of Technology Transfer (NIH-OTT) for the commercialization
of U.S. Patent #6,630,507, "Cannabinoids as Antioxidants and
Neuroprotectants" (the "'507 Patent").
The Kannaway convention kicks off Friday evening, April 18th
with a presentation introducing the company and a networking event
to follow. Saturday, April 19th is an all-day convention at which
the CBD-rich hemp oil product lines to be distributed by Kannaway
will be unveiled. The public can purchase admission to the Kannaway
convention; Brand Ambassadors who cannot attend the convention will
receive information on how to access the presentations through a
live video stream through: http://kannaway.com/payperview/
Industry leaders attending the Kannaway convention in support of
hemp-based CBD include: Natural News national radio show host
Robert Scott Bell; UFC Professional Athlete, Brandon Vera; Dr. Rob
Streisfeld and Dr. John Hicks III.
"People need to hear the real story behind hemp," continues
Rogers. "The fact that founding fathers like George Washington,
Thomas Jefferson and John Adams were all hemp farmers is something
we don't learn in school. We certainly never learned that America
and hemp were intertwined starting with the earliest settlers, and
it wasn't about getting 'high.' Hemp was simply a part of everyday
life prior to cannabis prohibition in 1937. This is THE story that
Americans need to hear, and we're the ones to tell it. We really
are more than just another network marketing company—we are a
movement with a pay plan."
Members of the media: Interviews with Company executives are
welcome, understanding that Kannaway executives have limited
availability during the convention. Media passes are required to
attend the Kannaway convention. Contact Denise Mahaffey of Malama
Marketing in advance at 760.908.6565 or denise@malamamarketing.com
to be placed on the media list.
About Kannaway, LLC
Kannaway, LLC, is a network sales and marketing company
specializing in the sales and marketing of hemp-based botanical
products. Kannaway currently hosts weekly online sales meetings and
conferences across the United States, offering unique insight and
opportunity to sales professionals who are desirous of becoming
successful leaders in the sale and marketing of hemp-based
botanical products. Kannaway currently has over 60,000 marketing
professionals in its network and more than 9,500 Brand
Ambassadors.
About KannaLife Sciences, Inc.
KannaLife Sciences, Inc. is a late stage bio-pharmaceutical and
phyto-medical company involved in the research and development of
novel new therapeutic agents designed as neuroprotectants,
immuno-modulators and reduce oxidative stress. KannaLife Sciences
currently holds an exclusive license with National Institutes of
Health – Office of Technology Transfer ("NIH-OTT") for the
Commercialization of U.S. Patent 6,630,507, "Cannabinoids as
Antioxidants and Neuroprotectants" (the "'507 Patent"). KannaLife
is currently conducting research and development at the
Pennsylvania Biotechnology Center in Doylestown, PA, for a target
drug candidate to treat Hepatic Encephalopathy ("HE"). HE is an
oxidative stress-related disease that affects the cognitive and
behavioral functions, and the wellness of the brain and the liver.
For more information, please visit KannaLife's website at:
www.kannalife.com
About HempMedsPX
HempMedsPX offers mainstream marketing, sales, customer
service, and logistics for the cannabis
industry. HempMedsPX is a corporate portfolio company
of Medical Marijuana, Inc. (OTC Pink:MJNA) and the
Company's exclusive master distributor and contracted
marketing company. In addition to handling sales and
distribution, HempMedsPX is the communication hub for the
Medical Marijuana Inc. portfolio of companies.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not
intended to diagnose, treat or cure any disease.
FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking
statements and information, as defined within the meaning of
Section 27A of the Securities Act of 1933 and Section 21E of the
Securities Exchange Act of 1934, and is subject to the Safe Harbor
created by those sections. This material contains statements about
expected future events and/or financial results that are
forward-looking in nature and subject to risks and uncertainties.
Such forward-looking statements by definition involve risks,
uncertainties and other factors, which may cause the actual
results, performance or achievements of Kannaway, LLC to be
materially different from the statements made herein.
LEGAL DISCLOSURE
Kannaway, LLC does not sell or distribute any products that are
in violation of the United States Controlled Substances Act
(US.CSA). The company does sell and distribute industrial
hemp-based products. Cannabidiol is a natural constituent of hemp
oil.
CONTACT: Corporate Contact:
Kannaway, LLC
619-600-KWAY
www.kannaway.com
www.facebook.com/WeAreKannaway
Medical Marijuana (PK) (USOTC:MJNA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Medical Marijuana (PK) (USOTC:MJNA)
Historical Stock Chart
From Apr 2023 to Apr 2024